Company intelligence / Profile preview

INNERCOOL Therapies

San Diego, California, USA

Ownership: Private
Development stage: Other

Overview

InnerCool Therapies is a medical technology company that developed advanced endovascular temperature management systems. Its flagship product, the Celsius Control System, uses a closed-loop metallic catheter to provide rapid and precise cooling or warming of a patient's core temperature. The technology is designed for use in critical care settings, specifically for therapeutic hypothermia following cardiac arrest or stroke, and for managing refractory fever in neurocritical patients. In 2009, the company was acquired by Philips Healthcare to enhance its emergency care and resuscitation business unit.

Therapeutic areas: CardiovascularNeurologyInfectious Diseases
Modalities: Device
Industry: Therapeutic Medical Devices

Beyond the preview

Go deeper on INNERCOOL Therapies.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on INNERCOOL Therapies.

Explore the full profile